DNA RNA and Cells

23 May 2007 Topigen Presents New Data on Its Phase II Asthma Product, TPI ASM8, at the American Thoracic Society Annual Meeting
23 May 2007 Genzyme Announces Publication in PNAS Describing Novel Gene Therapy Approach for Niemann Pick Disease
18 May 2007 Celladon and Targeted Genetics Initiate Phase I Clinical Trial of MYDICAR(TM) in Patients With Heart Failure
18 May 2007 Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients
17 May 2007 Cardium Initiates Phase 3 AWARE Clinical Study
15 May 2007 U.S. NCI Files for Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
10 May 2007 Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With Isis Pharmaceuticals
08 May 2007 Alnylam Reports Results of Human Experimental Infection Model with Respiratory Syncytial Virus
08 May 2007 FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
08 May 2007 Precursor Cells Generated From Human Embryonic Stem Cells Show Ability to Repair Vascular Damage in Animals
03 May 2007 Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
03 May 2007 Expression Genetics, Inc. Receives Orphan Drug Grant from FDA for Clinical Development of EGEN-001 for Treatment of Ovarian Cancer
03 May 2007 FDA Clearance Received For Heart Attack Stem Cell Clinical Trial
03 May 2007 Nucleonics Receives FDA Clearance to Begin Phase 1 Trial of Expressed RNAi Approach to Treating Chronic Hepatitis B Infections
02 May 2007 Cardium Advancing Excellarate to Phase 2b Clinical Study
02 May 2007 University College London, Moorfields Eye Hospital and Targeted Genetics Initiate Phase I/II Clinical Trial of Gene Therapy for Childhood Blindness
01 May 2007 Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
01 May 2007 New Report Illuminates Ampligen(R)'s Unique Mechanism of Action
28 Apr 2007 CHMP Adopts Negative Opinion on Genasense(R) Application in Melanoma
28 Apr 2007 Ark Therapeutics Grp - Regulatory Update
27 Apr 2007 Sangamo BioSciences Initiates Additional Phase 2 Clinical Trial of Novel Therapy for Moderate to Severe Diabetic Neuropathy
25 Apr 2007 Ark Therapeutics Grp - Research Update
19 Apr 2007 Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
18 Apr 2007 Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference
18 Apr 2007 Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up